首页 | 本学科首页   官方微博 | 高级检索  
     

小光斑飞点扫描准分子激光原位角膜磨镶术治疗LASIK术后残余近视
引用本文:米生健,段宇辉,李金科. 小光斑飞点扫描准分子激光原位角膜磨镶术治疗LASIK术后残余近视[J]. 中国激光医学杂志, 2009, 18(5): 305-307
作者姓名:米生健  段宇辉  李金科
作者单位:武警陕西省总队医院眼科,西安市,710054
摘    要:目的 评价小光斑飞点扫描准分子激光原位角膜磨镶术治疗LASIK术后残余近视的疗效及安全性.方法 对75例93只眼LASIK术后残余近视的患者行二次LASIK手术,全部采用掀瓣的手术方式,两次手术间隔(7.18±3.56)个月.术后平均随访超过6个月.结果 二次LASIK术后平均裸眼视力较术前显著提高(P<0.01),术后裸眼视力与术前最佳矫正视力比较,差异无显著意义(P>0.05);术后6个月时屈光度在±0.5 D以内者为90只眼(96.8%),20只眼(21.5%)术后裸眼视力大于术前最佳矫正视力.无危及视力的并发症出现.结论 小光斑飞点扫描准分子激光原位角膜磨镶术治疗LASIK术后残余近视安全、效果好.

关 键 词:准分子激光原位角膜磨镶术  残余近视  矫正

Laser in situ Keratomileusis Retreatment for Regression Using a Flying Spot Scanning Excimer Laser System
MI Sheng-jian,DUAN Yu-hui,LI Jin-ke. Laser in situ Keratomileusis Retreatment for Regression Using a Flying Spot Scanning Excimer Laser System[J]. Chinese Journal of Laser Medicine & Surgery, 2009, 18(5): 305-307
Authors:MI Sheng-jian  DUAN Yu-hui  LI Jin-ke
Abstract:Objective To evaluate the effectiveness and safety of laser in situ keratomileusis (LASIK) for residual myopia and astigmatism using ascanning-spot laser.Methods Ninety-three myopia eyes (from 75 patients) underwent secondary LASIK at (7. 18 ?3. 56) months after primary LASIK procedure. Following up was 6 months. The statistical analysis of the data was made by the paired sampleit test.Results After retreatment, the uncorrected visual acuity (UCVA) improved significantly (P < 0. 01 ) , the UCVA after secondaryLASIK and the best corrected visual acuity (BCVA) after primary LASIK were with no significant difference(P>0. 05). At 6 months,the residual refractive error within ?. 5 D was 96. 8% (90 eyes). The rate of postoperative UCVA was 21. 5% (20eyes) , better than the preoperative BCVA . Severe complications were not observed.Conclusions The secondary LASIK is an effective and safe method to treat regression after primary LASIK using a flying spot scanningexcimer laser system.
Keywords:Laser in situ keratomileusis  Regression  Retreatment
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号